Greg Fuller, MD, PhD is the Vice President of Medical Affairs and Medical Director at Plus Therapeutics.
Before joining Plus, Dr. Fuller served as Professor and Chief Neuropathologist at The University of Texas M D Anderson Cancer Center in the Department of Pathology, with a joint appointment in the Department of Neuroradiology, where he was a faculty member from 1992 – 2023. He is certified by the American Board of Pathology in Anatomic Pathology and Neuropathology. Dr. Fuller has published over 400 papers in peer-reviewed scientific journals, over 60 book chapters, and two books. He was President of the United States and Canadian Academy of Pathology from 2011-2012.
Dr. Fuller’s advocacy of the highest standards of excellence in Diagnostic Medicine, with investigative, patient care, and didactic skills honed over 47 years of rigorous training and academic service, has influenced successive waves of young physicians and scientists.
A three-decade tenure at MDACC enabled Dr. Fuller to exercise an educational reach of global dimensions, in terms of breadth, as illustrated by invited lectures at vanguard institutions worldwide, as well as in terms of depth, ranging from such apogee honors as being a Keynote Plenary Speaker at the historic 100th Anniversary Congress of the International Academy of Pathology, held in Montreal in 2006, down to the seemingly quotidian, but not in the least less important, presentation of multiple talks to Title I (low-income high-poverty) elementary and high school students in rural east Tennessee.
Dr. Fuller received his MD from Baylor College of Medicine, followed by his Residency in Anatomic Pathology and Fellowship in Neuropathology at Duke University. He earned his PhD from MD Anderson Cancer Center/UTHealth Graduate School of Biomedical Sciences, and his BS in Zoology from Texas A&M University (where he was inducted into the College of Science Academy of Distinguished Former Students).